Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted February 13, 2023
FDA Finds Prescription Drug in “100% Natural” Weight Loss Supplement
On February 8, 2023, the FDA warned consumers not to buy or use Alfia 100% Natural Weight Loss Capsules after FDA laboratory analysis confirmed the presence of sibutramine.
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking. N-desmethylsibutramine is similar to sibutramine.
Alfia Weight Loss Capsules (see product photo) are promoted for weight loss on the company’s website and various retail stores.
Consumers who have purchased these supplements should not use it and should contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Voluntary Reporting Program.
See ConsumerLab's Review of Weight Loss Supplements for more information and tests of related products.
For more information, use the link below.
Public Notification: Alfia Weight Loss Capsules contain hidden drug ingredient
See related recalls and warnings:
Prescription Drugs Found in Four Weight Loss Supplements
Male Sexual Enhancement Supplement Adam’s Secret Found to Contain Prescription Medication
FDA Warns Consumers Not to Use Male Enhancement Supplement
FDA Warns Sellers of Tainted Honey-Based Sexual Enhancement Products
FDA Finds Unapproved Drugs in Many Weight Loss and Sexual Enhancement Products Sold Online